{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:26:43Z","timestamp":1792070803757,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1439,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN 154285"],"award-info":[{"award-number":["FDN 154285"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL081588"],"award-info":[{"award-number":["HL081588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/jth.14304","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T02:34:31Z","timestamp":1537756471000},"page":"2375-2390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Genetic regulation of plasma von Willebrand factor levels in health and disease"],"prefix":"10.1016","volume":"16","author":[{"given":"L.L.","family":"Swystun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14304_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1111\/jth.14304_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII occurrence in effect of of deep\u2010vein thrombosis Willebrand factor","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/jth.14304_bb0030","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke: the Rotterdam study","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"key":"10.1111\/jth.14304_bb0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","article-title":"von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes","volume":"117","author":"Spiel","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.14304_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0049-3848(89)90317-4","article-title":"von Willebrand factor is an acute phase reactant in man","volume":"53","author":"Pottinger","year":"1989","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14304_bb0045","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","article-title":"ADAMTS\u201013, von Willebrand factor and related parameters in severe sepsis and septic shock","volume":"5","author":"Kremer Hovinga","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0050","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1046\/j.1538-7836.2003.00445.x","article-title":"Leptin increase is associated with markers of the hemostatic system in obese healthy women","volume":"1","author":"Guagnano","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell\u2010derived ultralarge von Willebrand\u2010factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0060","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/ATVBAHA.108.175679","article-title":"Differential role of von Willebrand factor and P\u2010selectin on microvascular thrombosis in endotoxemia","volume":"28","author":"Patel","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14304_bb0065","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/jth.13493","article-title":"Histones link inflammation and thrombosis through the induction of Weibel\u2013Palade body exocytosis","volume":"14","author":"Michels","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0070","doi-asserted-by":"crossref","first-page":"e2013052","DOI":"10.4084\/mjhid.2013.052","article-title":"Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease","volume":"5","author":"Castaman","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1111\/jth.14304_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jsams.2006.06.001","article-title":"Hemostatic response to acute physical exercise in healthy adolescents","volume":"10","author":"Ribeiro","year":"2007","journal-title":"J Sci Med Sport"},{"key":"10.1111\/jth.14304_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/ejh.12298","article-title":"Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations","volume":"93","author":"Timm","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.14304_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000112970","article-title":"Effects of cigarette smoking on hematological parameters and von Willebrand factor functional activity levels in asymptomatic male and female Arab smokers","volume":"17","author":"Al\u2010Awadhi","year":"2008","journal-title":"Med Princ Pract"},{"key":"10.1111\/jth.14304_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00277-013-1679-3","article-title":"Changes of plasma vWF level in response to the improvement of air quality: an observation of 114 healthy young adults","volume":"92","author":"Yuan","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1111\/jth.14304_bb0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-2006-947861","article-title":"Aspects of the laboratory identification of von Willebrand disease in women","volume":"32","author":"Kouides","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14304_bb0100","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1111\/jth.14304_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.1219885110","article-title":"Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome\u2010wide association","volume":"110","author":"Desch","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14304_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"De Lange","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/jth.14304_bb0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1538-7836.2005.01778.x","article-title":"Genetic influence on thrombotic risk markers in the elderly \u2013 a Danish twin study","volume":"4","author":"Bladbjerg","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0037-1613375","article-title":"Genome\u2010wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project","volume":"89","author":"Souto","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0125","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"10.1111\/jth.14304_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"key":"10.1111\/jth.14304_bb0140","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14304_bb0145","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/j.1460-2075.1986.tb04435.x","article-title":"Full\u2010length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit","volume":"5","author":"Verweij","year":"1986","journal-title":"EMBO J"},{"key":"10.1111\/jth.14304_bb0150","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14304_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14304_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jth.12093","article-title":"Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes","volume":"11","author":"Wang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0165","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2010-08-300152","article-title":"Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort","volume":"117","author":"Campos","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0170","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1182\/blood.V93.12.4277","article-title":"Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter","volume":"93","author":"Keightley","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0175","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1038\/ncomms16058","article-title":"Platelet function is modified by common sequence variation in megakaryocyte super enhancers","volume":"8","author":"Petersen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1111\/jth.14304_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.1090","article-title":"Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African\u2010American women","volume":"67","author":"Miller","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14304_bb0185","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African\u2010American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0190","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","article-title":"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project","volume":"122","author":"Johnsen","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co\u2010dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0200","first-page":"3517","article-title":"Heterogeneity of type 3 Von Willebrand disease (VWD): evidence from patient\u2010derived blood outgrowth endothelial cells (BOEC)","volume":"122","author":"Bowman","year":"2013","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"10.1111\/jth.14304_bb0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0215","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0220","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0225","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0230","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.thromres.2015.07.014","article-title":"Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534\u20103C>A von Willebrand factor mutation","volume":"136","author":"Casonato","year":"2015","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14304_bb0235","first-page":"331","article-title":"Critical importance of VWF propeptide (VWFpp) in the diagnosis of type 1 Von Willebrand disease (VWD)","volume":"21","author":"Haberichter","year":"2013","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"10.1111\/jth.14304_bb0240","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2009.03486.x","article-title":"Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM\u20101VWD study","volume":"7","author":"Eikenboom","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0245","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0250","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0255","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2009-12-261131","article-title":"Functional characterization of a 13\u2010bp deletion (c.\u20101522_\u20101510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease","volume":"116","author":"Othman","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0260","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM\u20101VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0265","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0270","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jth.12875","article-title":"von Willebrand factor arginine 1205 substitution results in accelerated macrophage\u2010dependent clearance in\u00a0vivo","volume":"13","author":"Rawley","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0275","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.13749","article-title":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","volume":"15","author":"Swystun","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0280","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2013-03-493312","article-title":"Accelerated uptake of VWF\/platelet complexes in macrophages contributes to VWD type 2B\u2010associated thrombocytopenia","volume":"122","author":"Casari","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0285","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14304_bb0290","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel\u00a0report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14304_bb0300","first-page":"453","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1111\/jth.14304_bb0305","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0310","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2017-09-807180","article-title":"Low VWF: an established mild bleeding disorder?","volume":"130","author":"Leebeek","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0315","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1538-7836.2006.01860.x","article-title":"Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study","volume":"4","author":"James","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0320","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0325","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.12194","article-title":"Reduced prevalence of arterial thrombosis in von Willebrand disease","volume":"11","author":"Sanders","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0330","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2141.2003.04776.x","article-title":"Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study","volume":"124","author":"van der Meer","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14304_bb0335","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood-2010-03-273961","article-title":"Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease","volume":"117","author":"van Schie","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0340","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1182\/blood-2010-10-315473","article-title":"Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0345","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","article-title":"von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population","volume":"10","author":"Van Loon","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0350","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2011.04243.x","article-title":"Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review","volume":"9","author":"van Schie","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0355","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.14304_bb0360","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/bloodadvances.2017011643","article-title":"The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance","volume":"2","author":"Mufti","year":"2018","journal-title":"Blood Adv"},{"key":"10.1111\/jth.14304_bb0365","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jth.13401","article-title":"Genome\u2010wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance","volume":"14","author":"Ozel","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0370","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1538-7836.2007.02325.x","article-title":"Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model","volume":"5","author":"Hemmerhirt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0375","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ejhg.2015.222","article-title":"Genome\u2010wide association studies identify genetic loci for low von Willebrand factor levels","volume":"24","author":"van Loon","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/jth.14304_bb0380","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1538-7836.2010.04092.x","article-title":"A multi\u2010stage multi\u2010design strategy provides strong evidence that the BAI3 locus is associated with early\u2010onset venous thromboembolism","volume":"8","author":"Antoni","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-12-102","article-title":"Combined analysis of three genome\u2010wide association studies on vWF and FVIII plasma levels","volume":"12","author":"Antoni","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1111\/jth.14304_bb0390","first-page":"102","article-title":"Multi\u2010ethnic genome\u2010wide association study identifies new loci regulating factor VIII and von Willebrand factor","volume":"1","author":"Sabater\u2010Llea","year":"2017","journal-title":"Res Pract Thromb Haemost (ISTH Congr Abstr)"},{"key":"10.1111\/jth.14304_bb0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20120810","article-title":"Mapping the N\u2010glycome of human von Willebrand factor","volume":"447","author":"Canis","year":"2012","journal-title":"Biochem J"},{"issue":"Suppl. 5","key":"10.1111\/jth.14304_bb0400","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2516.2010.02320.x","article-title":"Factor VIII and von Willebrand factor \u2013 too sweet for their own good","volume":"16","author":"Lenting","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14304_bb0405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2010-02-267450","article-title":"Specific N\u2010linked glycosylation sites modulate synthesis and secretion of von Willebrand factor","volume":"116","author":"McKinnon","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0410","doi-asserted-by":"crossref","first-page":"e37508","DOI":"10.1371\/journal.pone.0037508","article-title":"In vivo analysis of the role of o\u2010glycosylations of von Willebrand factor","volume":"7","author":"Badirou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14304_bb0415","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood-2005-02-0792","article-title":"Bombay phenotype is associated with reduced plasma\u2010VWF levels and an increased susceptibility to ADAMTS13 proteolysis","volume":"106","author":"O'Donnell","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0420","first-page":"334","article-title":"Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults","volume":"125","author":"Green","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.14304_bb0425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2141.2002.03270.x","article-title":"Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level","volume":"116","author":"O'Donnell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14304_bb0430","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0435","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/j.1538-7836.2010.03957.x","article-title":"Blood group significantly influences von Willebrand factor increase and half\u2010life after desmopressin in von Willebrand disease Vicenza","volume":"8","author":"Castaman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0440","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jth.12867","article-title":"No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance","volume":"13","author":"Groeneveld","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0445","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH07-09-0565","article-title":"Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations","volume":"99","author":"Millar","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0450","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/jth.14304_bb0455","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.142005099","article-title":"Sialyltransferase ST3Gal\u2010IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands","volume":"99","author":"Ellies","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14304_bb0460","first-page":"1","article-title":"Association of single nucleotide polymorphisms in the ST3GAL4 gene with VWF antigen and factor VIII activity","volume":"11","author":"Song","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14304_bb0465","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin\u2010induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14304_bb0470","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1538-7836.2010.03884.x","article-title":"Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels","volume":"8","author":"Nossent","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0475","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198804073181403","article-title":"Hemodynamic and coagulation responses to 1\u2010desamino(8\u2010D\u2010Arginine) vasopressin in patients with congenital nephrogenic diabetes insipidus","volume":"318","author":"Bichet","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14304_bb0480","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0735-1097(98)00251-4","article-title":"Endothelial cell damage and angiotensin\u2010converting enzyme insertion\/deletion genotype in elderly hypertensive patients","volume":"32","author":"Kario","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.14304_bb0485","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1172\/JCI75572","article-title":"Platelet secretion and hemostasis require syntaxin\u2010binding protein STXBP5","volume":"124","author":"Ye","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14304_bb0490","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1172\/JCI71245","article-title":"Syntaxin\u2010binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion","volume":"124","author":"Zhu","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14304_bb0495","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Sanders","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0040624","article-title":"Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in\u00a0type 1 von Willebrand disease patients","volume":"7","author":"van Loon","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14304_bb0505","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCGENETICS.110.957407","article-title":"Effect of genetic variations in syntaxin\u2010binding protein\u20105 and syntaxin\u20102 on von Willebrand factor concentration and cardiovascular risk","volume":"3","author":"Van Loon","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1111\/jth.14304_bb0510","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2013-10-535831","article-title":"STXBP1 promotes Weibel\u2013Palade body exocytosis through its interaction with the Rab27A effector Slp4\u2010a","volume":"123","author":"Van Breevoort","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0515","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2012-05-430603","article-title":"Syntaxin\u201011, but not syntaxin\u20102 or syntaxin\u20104, is required for platelet secretion","volume":"120","author":"Ye","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0520","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3324\/haematol.2012.063297","article-title":"Factor VIII and von Willebrand factor are ligands for the carbohydrate\u2010receptor Siglec\u20105","volume":"97","author":"Pegon","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/jth.14304_bb0525","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0530","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2004-11-4230","article-title":"LDL receptor cooperates with LDL receptor\u2010related protein in regulating plasma levels of coagulation factor VIII in\u00a0vivo","volume":"106","author":"Bovenschen","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0535","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1538-7836.2005.01389.x","article-title":"The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor","volume":"3","author":"Bovenschen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0540","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3324\/haematol.2017.175216","article-title":"Macrophage scavenger\u2010receptor SR\u2010AI contributes to the clearance of von Willebrand factor","volume":"103","author":"Wohner","year":"2018","journal-title":"Haematologica"},{"key":"10.1111\/jth.14304_bb0545","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2017-06-787853","article-title":"A novel role for the macrophage galactose\u2010type lectin receptor in mediating von Willebrand factor clearance","volume":"131","author":"Ward","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0550","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2004.05275.x","article-title":"Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort","volume":"128","author":"Morange","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14304_bb0555","first-page":"497","article-title":"Low\u2010density lipoprotein receptor\u2010related protein 1 (LRP1) polymorphism 663 C>T affects clotting factor VIII activity and increases the risk of venous thromboembolism","volume":"108","author":"Vormittag","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0560","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C\u2010type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0565","first-page":"98","article-title":"The endothelial lectin CLEC4M is a novel clearance receptor for factor VIII","volume":"11","author":"Swystun","year":"2013","journal-title":"J Thromb Haemost (ISTH Congr Abstr)"},{"key":"10.1111\/jth.14304_bb0570","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin\u20102 regulates VWF\u2013FVIII complex half\u2010life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14304_bb0575","first-page":"457","article-title":"Exome sequencing studies identify mutations in STAB 2 as a genetic risk for venous thromboembolic disease","volume":"126","author":"Desch","year":"2017","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"10.1111\/jth.14304_bb0580","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2015-02-624551","article-title":"Rare and low\u2010frequency variants and their association with plasma levels","volume":"126","author":"Huffman","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14304_bb0585","first-page":"3794","article-title":"Exome sequencing in venous thromboembolic disease identifies excess mutation burden in PROS1, PROC, SERPINC1, STAB 2","volume":"128","author":"Desch","year":"2016","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"10.1111\/jth.14304_bb0590","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ajpath.2013.01.042","article-title":"Progressive reactive lymphoid connective tissue disease and development of autoantibodies in scavenger receptor A5\u2010deficient mice","volume":"182","author":"Ojala","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.14304_bb0595","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.devcel.2008.12.002","article-title":"Scara5 is a ferritin receptor mediating non\u2010transferrin iron delivery","volume":"16","author":"Li","year":"2009","journal-title":"Dev Cell"},{"key":"10.1111\/jth.14304_bb0600","doi-asserted-by":"crossref","first-page":"11834","DOI":"10.1074\/jbc.M507599200","article-title":"Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells","volume":"281","author":"Jiang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1111\/jth.14304_bb0605","first-page":"222","article-title":"Scavenger receptor class A member 5 (SCARA5) binds and internalizes VWF in\u00a0vitro: a novel candidate VWF clearance receptor","volume":"13","author":"Ogiwara","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0610","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1538-7836.2010.04012.x","article-title":"von Willebrand factor clearance does not involve proteolysis by ADAMTS\u201013","volume":"8","author":"Badirou","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0615","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2009.03.008","article-title":"Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease","volume":"125","author":"Schettert","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14304_bb0620","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/ATVBAHA.107.141713","article-title":"Thrombospondins, their polymorphisms, and cardiovascular disease","volume":"27","author":"Stenina","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14304_bb0625","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-5793(01)02738-7","article-title":"Tac2\u2010N, an atypical C\u2010type tandem C2 protein localized in the nucleus","volume":"503","author":"Fukuda","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1111\/jth.14304_bb0630","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1538-7836.2010.04082.x","article-title":"Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels","volume":"9","author":"Morange","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0635","first-page":"1","article-title":"Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects","volume":"10","author":"Song","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14304_bb0640","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2015.03.330","article-title":"Distribution, genetic and cardiovascular determinants of FVIII:c \u2013 data from the population\u2010based Gutenberg Health Study","volume":"187","author":"Hermanns","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.14304_bb0645","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0037-1613759","article-title":"The half\u2010life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A","volume":"83","author":"Vlot","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14304_bb0650","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hae.12592","article-title":"Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A","volume":"21","author":"Kepa","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14304_bb0655","first-page":"473","article-title":"Clearance and genetic variability of Von Willebrand factor are major determinants of the pharmacokinetic behavior of factor VIII concentrates in the treatment of pediatric hemophiliaA","volume":"123","author":"Ogiwara","year":"2014","journal-title":"Blood (ASH Annu Meet Abstr)"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202949X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202949X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14304\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:23:49Z","timestamp":1761535429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362202949X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":130,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S153878362202949X"],"URL":"https:\/\/doi.org\/10.1111\/jth.14304","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic regulation of plasma von Willebrand factor levels in health and disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}